Skip to Content
Morningstar
Get 14 Days Free

UnitedHealth Group Inc UNH

Morningstar Rating
Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

UnitedHealth Slightly Beats Q3 Expectations and Raises 2021 Outlook; No FVE Change

Julie Utterback, CFA Senior Equity Analyst

Analyst Note

| Julie Utterback, CFA |

UnitedHealth Group reported third-quarter results that beat market consensus, and management raised 2021 guidance a bit. We do not anticipate changing our fair value estimate significantly, though, since our profit estimates were already within the new outlook range. UnitedHealth shares continue to look moderately rich to us, especially relative to managed-care organization peers that have similar growth trajectories and risk profiles. Like its peers, UnitedHealth's economic moat remains narrow, which recognizes a top-tier position in medical insurance, pharmacy benefits, caregiving services, and analytical tools offset slightly by long-term policy risks in end markets. 

Read Full Analysis

Company Profile

Business Description

UnitedHealth Group is the largest private health insurance provider in the United States, providing medical benefits to 48 million members across its U.S. and international businesses at the end of 2020. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Contact
9900 Bren Road East, UnitedHealth Group Center
Minnetonka, MN, 55343
T +1 952 936-1300
Sector Healthcare
Industry Healthcare Plans
Most Recent Earnings Jun 30, 2021
Fiscal Year End Dec 31, 2021
Stock Type Aggressive Growth
Employees 330,000

Related

Stock Strategist Industry Reports
Healthcare Policy Changes Could Result in Opportunities
Expanded insurance rolls would be good news for the managed-care organizations and service providers we cover.
Julie Utterback
Investing Specialists
Our Ultimate Stock-Pickers' Top 10 Buys and Sells
Funds see value in a diverse range of sectors.
Justin Pan
Market Update
Digging Into Vanguard Dividend Growth
The fund stands out for its focus on companies with a strong competitive advantage that can sustain and grow their dividends over time.
Amy C. Arnott
Stock Analyst Update
Supreme Court Ruling to Uphold ACA
This decision adds certainty to related health insurance programs.
Julie Utterback
Market Update
Globalization Declining? Not in Investor Portfolios
Morningstar Indexes through a geographic revenue lens.
Dan Lefkovitz
Fund Spy
A Terrific, Time-Tested Dividend-Growth Fund
An upcoming organizational change isn't a concern for Silver-rated T. Rowe Price Dividend Growth.
Stephen Welch
Our Picks
10 Stocks to Own
These names are widely held among some of our favorite concentrated-fund managers.
Susan Dziubinski
Our Picks
21 Standout Companies Run by Women
These firms have carved out economic moats and are led by female CEOs.
Susan Dziubinski
Fund Spy
Fidelity Contrafund Continues to Impress
The behemoth's merits are substantial.
Robby Greengold
Stock Analyst Update
UnitedHealth Maintains Earnings Guidance for 2021
We do not plan on changing our moat rating or fair value estimate for the company.
Julie Utterback
Commentary
The Week Ahead: Netflix, P&G, and Intel to Report Earnings
We also are looking out for other big names to report in the week ahead.
Carole Hodorowicz
Stock Strategist Industry Reports
What a Democratic Sweep Means for Healthcare
We think the insurers could be most influenced by potential reforms.
Julie Utterback
Stock Analyst Update
Why We Are Raising UnitedHealth's Fair Value Estimate
The firm's near-term outlook looks slightly higher than our expectations.
Julie Utterback
Investing Specialists
Our Ultimate Stock-Pickers' Top 10 Buys and Sells
Funds sell technology, buy basic materials and financial services.
Malik Ahmed Khan
Commentary
Finally Time for Value Stocks to Shine?
As the pathway to economic normalization in 2021 becomes clear, the market has begun to favor value stocks over growth stocks.
David Sekera
Stock Analyst Update
UnitedHealth Reports Strong Q3, Conservative on 2021
Despite a conservative 2021 outlook, we're maintaining our fair value estimate for the narrow-moat company.
Julie Utterback
Commentary
The Week Ahead: Delta, Johnson & Johnson, and Morgan Stanley Among Companies to Kick Off Third-Quarter Earnings
We are on the lookout for a week stacked with reports from names in the financials, healthcare, and industrials sectors.
Carole Hodorowicz
Investing Specialists
Our Ultimate Stock-Pickers' Top 10 Buys and Sells
Funds focus purchases in basic materials and consumer sectors.
Nupur Balain
Stock Analyst Update
UnitedHealth Reports Strong Second Quarter
We are not making any changes to our 2020 outlook and fair value estimate for the narrow-moat company.
Julie Utterback
Investing Specialists
Top 10 Holdings of Our Ultimate Stock-Pickers' Index
Large-cap strategies disappoint on the back of stock market volatility at the end of 2019.
Nupur Balain